CMS Grants New Technology Add-on Payment to ZEMDRI™ (plazomicin)
--- Add-on Payment to Provide Additional Medicare Reimbursement up to 50% of the cost of ZEMDRI Prescribed to Medicare patients in Hospital Inpatient Setting --- SOUTH SAN FRANCISCO, Calif., Aug. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a …